Cargando…

Clinical Outcome of Hospitalized COVID-19 Patients with History of Atrial Fibrillation

Background and objectives: Pre-existing atrial fibrillation (AF) is a frequent comorbidity in hospitalized patients with COVID-19; however, little is still known about its prognostic role in infected patients. The aim of our study was to evaluate whether the pre-existing AF as comorbidity would cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russo, Vincenzo, Silverio, Angelo, Scudiero, Fernando, D’Andrea, Antonello, Attena, Emilio, Di Palma, Gisella, Parodi, Guido, Caso, Valentina, Albani, Stefano, Galasso, Gennaro, Imbalzano, Egidio, Golino, Paolo, Di Maio, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951344/ https://www.ncbi.nlm.nih.gov/pubmed/35334575 http://dx.doi.org/10.3390/medicina58030399

Ejemplares similares

Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients
por: Russo, Vincenzo, et al.
Publicado: (2021)

Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome
por: Scudiero, Fernando, et al.
Publicado: (2021)

Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation
por: Falco, Luigi, et al.
Publicado: (2023)

Clinical conditions and echocardiographic parameters associated with mortality in COVID‐19
por: Silverio, Angelo, et al.
Publicado: (2021)

Pre-admission atrial fibrillation in COVID-19 patients: Prevalence and clinical impact
por: Russo, Vincenzo, et al.
Publicado: (2021)

Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation
por: Carbone, Andreina, et al.
Publicado: (2022)

Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study
por: Russo, Vincenzo, et al.
Publicado: (2020)

Prognostic Implications of Right Ventricular Function and Pulmonary Pressures Assessed by Echocardiography in Hospitalized Patients with COVID-19
por: Polito, Maria Vincenza, et al.
Publicado: (2021)

Long-Term Prognostic Impact of Right Ventricular Dysfunction in Patients with COVID-19
por: Scudiero, Fernando, et al.
Publicado: (2022)

Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response
por: Rago, Anna, et al.
Publicado: (2023)

Direct Current Cardioversion in Atrial Fibrillation Patients on Edoxaban Therapy Versus Vitamin K Antagonists: a Real-world Propensity Score–Matched Study
por: Rago, Anna, et al.
Publicado: (2020)

Triple troubles selecting optimal therapy for atrial fibrillation patients undergoing percutaneous coronary interventions
por: Parodi, Guido, et al.
Publicado: (2016)

Clinical Outcome of Edoxaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation and Diabetes Mellitus: Results from a Multicenter, Propensity-Matched, Real-World Cohort Study
por: Russo, Vincenzo, et al.
Publicado: (2020)

Non Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients Scheduled for Electrical Cardioversion: A Real-Life Propensity Score Matched Study
por: Rago, Anna, et al.
Publicado: (2021)

Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study
por: Russo, Vincenzo, et al.
Publicado: (2019)

Timing of national lockdown and mortality in COVID-19: The Italian experience
por: Silverio, Angelo, et al.
Publicado: (2020)

The Impact of COVID-19 Pandemic on Hospitalization and Interventional Procedures for Cardiovascular Diseases during the First Wave in Italy
por: Russo, Vincenzo, et al.
Publicado: (2022)

Epicardial Adipose Tissue and Cardiac Arrhythmias: Focus on Atrial Fibrillation
por: Conte, Maddalena, et al.
Publicado: (2022)

Single-Chamber Leadless Cardiac Pacemaker in Patients Without Atrial Fibrillation: Findings From Campania Leadless Registry
por: Russo, Vincenzo, et al.
Publicado: (2022)

Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation
por: Imbalzano, Egidio, et al.
Publicado: (2022)

Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
por: Scarano, Michele, et al.
Publicado: (2017)

Clinical Performance of Oral Anticoagulants in Elderly with Atrial Fibrillation and Low Body Weight: Insight into Italian Cohort of PREFER-AF and PREFER-AF Prolongation Registries
por: Russo, Vincenzo, et al.
Publicado: (2022)

Heparin and SARS-CoV-2: Multiple Pathophysiological Links
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?
por: Polito, Maria Vincenza, et al.
Publicado: (2021)

Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study—The ISNEP Study
por: De Stefano, Francesco, et al.
Publicado: (2022)

The prognostic role of interatrial block among COVID‐19 patients hospitalized in medicine wards
por: Russo, Vincenzo, et al.
Publicado: (2022)

Big Health Data and Cardiovascular Diseases: A Challenge for Research, an Opportunity for Clinical Care
por: Silverio, Angelo, et al.
Publicado: (2019)

Editorial: Advances in Percutaneous Coronary Intervention
por: Silverio, Angelo, et al.
Publicado: (2022)

The Impact of the COVID-19 Outbreak on Patients’ Adherence to PCSK9 Inhibitors Therapy
por: Caso, Valentina Maria, et al.
Publicado: (2022)

COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives
por: Esposito, Luca, et al.
Publicado: (2021)

New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress
por: Bagnato, Gianluca, et al.
Publicado: (2022)

Dynamic Left Intraventricular Obstruction Phenotype in Takotsubo Syndrome
por: Di Vece, Davide, et al.
Publicado: (2021)

Upstream Therapy for Atrial Fibrillation Prevention: The Role of Sacubitril/Valsartan
por: De Vecchis, Renato, et al.
Publicado: (2020)

Left Ventricular Deformation and Vortex Analysis in Heart Failure: From Ultrasound Technique to Current Clinical Application
por: Sperlongano, Simona, et al.
Publicado: (2021)

Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients
por: Silverio, Angelo, et al.
Publicado: (2021)

Secondary Prevention of Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study
por: De Vecchis, Renato, et al.
Publicado: (2019)

Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma
por: Esposito, Luca, et al.
Publicado: (2022)

Effects of High Intensity Interval Training Rehabilitation Protocol after an Acute Coronary Syndrome on Myocardial Work and Atrial Strain
por: D’Andrea, Antonello, et al.
Publicado: (2022)

Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes
por: Silverio, Angelo, et al.
Publicado: (2022)

Impella in Takotsubo syndrome complicated by left ventricular outflow tract obstruction and severe mitral regurgitation
por: Attisano, Tiziana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t4b6vctk9gv9jq82gf50haj6nk